Sector

Therapeutics

Source

Imperial College London

Thiakis was a biotechnology company developing TKS1225, an analogue of the peptide hormone oxyntomodulin, for the treatment of obesity, including the prevention and amelioration of diseases associated with excess weight such as type 2 diabetes.

The business was acquired in 2008 by US-based Wyeth Pharmaceuticals (now Pfizer).